Update information

Update information

September 2019: This topic was removed from the retired list and included in the 2019 rapid update of medicines optimisation: key therapeutic topics. Editorial changes have been completed, 2 medicines evidence commentaries have been added, information about outcome studies for PCSK9 inhibitors have been added, and text has been updated to reflect the price change for rosuvastatin.